Founded in 1994, Bavarian Nordic has through the last nearly
twenty years built a solid platform for developing modern vaccines
for the treatment and prevention of life-threatening diseases.
Our proprietary MVA-BN® (Modified vaccinia Ankara - Bavarian
Nordic) vaccine vector technology with its unique safety
profile is the foundation for most of the company's vaccines and
with the world's only dedicated facility for the manufacturing of
MVA vaccines, the company is leading in the field of MVA.
Our core competences are:
